Zimmer Biomet Operating Income Over Time
| ZBH Stock | USD 99.25 1.00 1.02% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Zimmer Biomet Performance and Zimmer Biomet Correlation. Is there potential for Health Care Equipment & Supplies market expansion? Will Zimmer introduce new products? Factors like these will boost the valuation of Zimmer Biomet. Anticipated expansion of Zimmer directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.41) | Dividend Share 0.96 | Earnings Share 3.55 | Revenue Per Share | Quarterly Revenue Growth 0.109 |
Zimmer Biomet Holdings's market price often diverges from its book value, the accounting figure shown on Zimmer's balance sheet. Smart investors calculate Zimmer Biomet's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Zimmer Biomet's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Operating Income Analysis
Compare Zimmer Biomet Holdings and related stocks such as Smith Nephew SNATS, Quest Diagnostics, and STERIS plc Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SNN | 127.9 M | 862 M | 846 M | 810 M | 749 M | 628 M | 801 M | 934 M | 863 M | 815 M | 295 M | 593 M | 315 M | 425 M | 657 M | 755.5 M | 500.2 M |
| DGX | (601.3 M) | 995 M | 1.2 B | 1.5 B | 983 M | 1.4 B | 1.3 B | 1.2 B | 1.1 B | 1.2 B | 2 B | 2.4 B | 1.4 B | 1.3 B | 1.3 B | 1.6 B | 1.1 B |
| STE | 200 K | 222.3 M | 242.8 M | 206.8 M | 227.2 M | 212.9 M | 226.2 M | 399.9 M | 411 M | 537 M | 548.4 M | 477.8 M | 791.1 M | 836.1 M | 866.6 M | 996.6 M | 1 B |
| WAT | 56.4 M | 528.6 M | 511.5 M | 517.3 M | 517.9 M | 567.5 M | 625 M | 662.2 M | 739.8 M | 708.5 M | 645.5 M | 821.7 M | 873.4 M | 817.7 M | 826.4 M | 893.2 M | 495.2 M |
| ILMN | (5.9 M) | 199.5 M | 200.8 M | 134.1 M | 514.7 M | 613 M | 587 M | 606 M | 883 M | 985 M | 393 M | (123 M) | (4.2 B) | (1.1 B) | (833 M) | 865 M | 908.2 M |
| WST | 23.5 M | 115.9 M | 136.5 M | 162.4 M | 182 M | 128.6 M | 196.8 M | 228.9 M | 254.8 M | 297.2 M | 419 M | 758.7 M | 763.5 M | 710.9 M | 594.6 M | 617.4 M | 648.3 M |
| DXCM | (4 M) | (44.8 M) | (55.7 M) | (28.9 M) | (21.5 M) | (57.1 M) | (63.9 M) | (42.5 M) | (186.3 M) | 142.3 M | 299.5 M | 265.8 M | 391.2 M | 597.7 M | 600 M | 911.8 M | 957.4 M |
| INCY | (4.9 M) | (143.2 M) | 1.1 M | (16.1 M) | (4.8 M) | 50.7 M | 164 M | (235.7 M) | 155.4 M | 421.7 M | (240.3 M) | 637.5 M | 599.6 M | 651.8 M | 80.1 M | 1.3 B | 1.4 B |
| LH | 313.9 M | 948.4 M | 1 B | 990.9 M | 910.4 M | 1 B | 1.3 B | 1.4 B | 1.3 B | 1.3 B | 2.4 B | 3 B | 1.4 B | 725.6 M | 1.1 B | 1.5 B | 836.4 M |
| UTHR | (13.3 M) | 317.8 M | 421.6 M | 292.5 M | 538.8 M | 699 M | 1.1 B | 814.9 M | 805.4 M | (187.6 M) | 593.6 M | 555.9 M | 979.7 M | 1.2 B | 1.4 B | 1.6 B | 1.7 B |
Zimmer Biomet Holdings and related stocks such as Smith Nephew SNATS, Quest Diagnostics, and STERIS plc Operating Income description
Operating Income is the amount of profit realized from Zimmer Biomet Holdings operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Zimmer Biomet Holdings is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Zimmer Biomet Holdings | ZBH |
| Classification | Obamacare Repeal |
| Business Address | 345 East Main |
| Exchange | New York Stock Exchange |
USD 99.25
Check out Zimmer Biomet Performance and Zimmer Biomet Correlation. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Zimmer Biomet technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.